Skip to main content
OpenTrials
Completed

NCT Number: NCT05506020

Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy

The purpose of this study was to assess the effects of indocyanine green (ICG) fluorescence cholangiography during laparoscopic left lateral sectionectomy (LLLS) on the occurrence of biliary complications in both donors and recipients in living donor liver transplantation (LDLT) and to explore the optimal dose and injection time of ICG.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Living Donor Liver Transplantation

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This was a retrospective cohort study. The purpose of this study was to assess the effects of indocyanine green (ICG) fluorescence cholangiography during LLLS on the occurrence of biliary complications in both donors and recipients. The optimal dose and injection time of ICG were also investigated. From October 2016 to May 2022, the clinical data of 85 donors who underwent LLLS and relevant recipients in the Department of General Surgery of Huashan Hospital were retrospectively analyzed. According to whether ICG fluorescence cholangiography was used, they were divided into a non-ICG group (n=46) and an ICG group (n=39). Biliary complications were observed and the optimal dose and injection time of ICG were explored.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • From October 2016 to May 2022, donors and their corresponding recipients underwent laparoscopic donor liver acquisition surgery in the general surgery department of Huashan Hospital.
  • Donor age ≥ 18 years old, regardless of gender; The receptor is the corresponding receptor of the donor, and the age and sex of the receptor are unlimited.
  • The medical history is complete, which can meet the requirements of this study.
  • Volunteer to participate in this study.

Exclusion criteria

  • The medical history is incomplete, which cannot meet the requirements of this study.
  • The donor or recipient expressly refused to participate in this study.

Treatment and study plan

indocyanine green (ICG) fluorescence cholangiography

Procedure

indocyanine green (ICG) fluorescence cholangiography during operation

Primary outcomes

  1. Biliary complications

    Time frame: two months after operation

    bile leakage and biliary stenosis

Sponsors and collaborators

Lead sponsor

Fudan University

Other

Registry information

Official study title

Retrospective Study on the Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy

Important dates

Study start
2016
Primary completion
2022
Study completion
2022
First posted
Aug 18, 2022
Registry last updated
Aug 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.